ANL vs REGN: Which Stock is Better?
Side-by-side comparison of Adlai Nortye Ltd and Regeneron Pharmaceuticals Inc in 2026
ANL
Adlai Nortye Ltd
$8.38
REGN
Regeneron Pharmaceuticals Inc
$759.86
Key Metrics Comparison
| Metric | ANL | REGN | Winner |
|---|---|---|---|
| Market Cap | $295.57M | $80.87B | REGN |
| P/E Ratio | N/A | 18.45 | REGN |
| EPS (TTM) | $N/A | $41.46 | REGN |
| Revenue Growth | 1.2% | 0.0% | ANL |
| Gross Margin | 100.0% | 44.6% | ANL |
Analyze ANL
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ANL or REGN a better investment?
Comparing ANL and REGN: Adlai Nortye Ltd has a market cap of $295.57M while Regeneron Pharmaceuticals Inc has $80.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ANL and REGN?
ANL (Adlai Nortye Ltd) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ANL or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ANL or REGN?
ANL has higher revenue growth at 1.2% vs 0.0% for REGN.
Which company is more profitable: ANL or REGN?
Adlai Nortye Ltd (ANL) has higher gross margins at 100.0% compared to 44.6% for REGN.
Which is the larger company: ANL or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $80.87B compared to $295.57M for ANL.
Should I buy ANL or REGN in 2026?
Both ANL and REGN have investment merit. ANL trades at $8.38 while REGN trades at $759.86. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ANL and REGN stock?
Key differences: Market Cap ($295.57M vs $80.87B), P/E Ratio (N/A vs 18.4x), Revenue Growth (1.2% vs 0.0%), Gross Margin (100.0% vs 44.6%).